key: cord-0786870-j6tn1hk3
authors: Leta, Valentina; Rodríguez‐Violante, Mayela; Abundes, Arturo; Rukavina, Katarina; Teo, James T.; Falup‐Pecurariu, Cristian; Irincu, Laura; Rota, Silvia; Bhidayasiri, Roongroj; Storch, Alexander; Odin, Per; Antonini, Angelo; Ray Chaudhuri, Kallol
title: Parkinson's Disease and Post–COVID‐19 Syndrome: The Parkinson's Long‐COVID Spectrum
date: 2021-04-28
journal: Mov Disord
DOI: 10.1002/mds.28622
sha: 70a17831c791a66b6113303d7538e67c29bb13f3
doc_id: 786870
cord_uid: j6tn1hk3

nan

a prolonged lockdown due to the pandemic and the reduced access to health care and rehabilitation interventions may contribute to the burden of the post-COVID-19 syndrome in PD. Therefore, post-COVID clinical manifestations may result from a combination of new symptoms and lockdown as well as viral illness-related worsening of preexisting PD features.

In conclusion, this is the first multicenter case series investigating the occurrence of post-COVID-19 syndrome in patients with PD. The small sample size and the lack of a controlled group make it challenging to draw any firm conclusions; nevertheless, we believe our case series is meaningful as it highlights the possibility of the existence of a post-COVID-19 syndrome in most patients with PD recovering from acute COVID-19. There is a clear need for greater awareness of this issue among health care professionals, and further studies are required with longitudinal follow-up of a larger cohort of patients with PD to address the natural history of the reported symptoms and with a view to developing personalized management strategies. 

Outcome of Parkinson's disease patients affected by COVID-19

Coronavirus disease 2019 case fatality and Parkinson's disease

COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside

COVID-19 in Parkinson's disease: Report on prevalence and outcome

Effects of COVID-19 on Parkinson's disease clinical features: a community-based case-control study

National Institute for Health and Care Excellence (NICE)

COVID-19 rapid guideline: managing the long-term effects of COVID-19

Characterizing long COVID in an international cohort: 7 months of symptoms and their impact